President Donald Trump’s administration on Tuesday rolled out an executive action aimed at limiting direct-to-consumer advertising for pharmaceuticals, with officials saying a recent Hims & Hers Health Inc. ad stood out as an example of what should be prevented.
Trending
- Jiuzi Holdings, Inc. Partners With SOLV Foundation On $2.8B TVL Bitcoin Initiative To Advance Crypto Treasury Strategy
- New Crypto Mutuum Finance (MUTM) Announces V1 Protocol as Investor Count Tops 17,400
- Circle USDC Mint Boosts Solana DeFi Liquidity
- Best CD rates today, October 26, 2025 (lock in up to 4.1% APY)
- XRP flips BNB to rank as 3rd largest cryptocurrency
- Trader Who Made $190M In Crypto Crash Predicted CZ’s Pardon
- Dividend Stocks: Infosys, CESC, Tanla Platforms, among others to trade ex-dividend next week; Full list here
- MultiBank Group and Khabib Nurmagomedov Launch an Exclusive Worldwide Multi-Billion-Dollar Joint Venture to Build the World’s First Regulated Tokenized Sports Ecosystem.
